The funding round was co-led by KHP Ventures and Cedars-Sinai Intellectual Property Co.
"This round represents a significant leap forward for 52North. With support from both UK and US healthcare leaders, we can expand our product pipeline working with major strategic partners and appropriately leverage the latest tools including AI to reshape urgent care pathways for patients worldwide. The commitment from both KHP Ventures and Cedars-Sinai exemplifies the belief in our vision and the value of our solutions."
The Cambridge wound care company raised the Series C financing from existing backers to fund US market expansion and product reimbursement.
"Amadeus backed Natrox from inception and it is fulfilling to see this best-in-class technology now available in a growing number of markets. NATROX O₂ is already authorised to sell in 46 countries. It is becoming the reference advance therapy for the healing of chronic wounds across private and public health systems globally. Securing national coverage in the US is another step forward for the team."
SFC Capital led the pre-seed round to help accelerate the rollout of the company's B2B healthcare platform.
"This investment is a significant milestone in our journey to transform chronic disease management. By integrating personalised AI-driven and evidence-based self-care into existing medical pathways, we aim to deliver better outcomes for patients and unlock value for healthcare providers and payers."
The seed round was led by EMV Capital and includes participation from Animal Health Angels.
"SageTech Medical’s mission aligns perfectly with our vision of fostering groundbreaking innovations that benefit the wider animal health ecosystem. Their commitment to sustainability and environmental stewardship is inspiring, and we are thrilled to play a role in their growth journey."
The Cardiff-based medical technology firm raised pre-seed funding led by SFC Capital and OVC Ventures to expand its home diagnostic tools.
"By empowering patients with innovative tools and ensuring they are remotely monitored by clinicians, we’re shaping the future of healthcare to be more accessible, personalised, and efficient. We are grateful to our investors and grant partners for their support in making this vision a reality."
.png)
.png)
